# Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis

> **NCT01252420** · PHASE4 · UNKNOWN · sponsor: **Monash Medical Centre** · enrollment: 330 (estimated)

## Conditions studied

- Venous Thrombosis
- Pulmonary Embolism

## Interventions

- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT01252420
- **Lead sponsor:** Monash Medical Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** 2013-11
- **Final completion:** 2014-11
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2010-12-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01252420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01252420, "Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01252420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*